JW Therapeutics

药明巨诺

JW Therapeutics

Biotech/Healthcare

JW Therapeutics (药明巨诺) is a CAR-T cell immunotherapy technology developer jointly established in China by Juno Therapeutics (NASDAQ: JUNO), a global leader in tumor cell immunotherapy, and WuXi AppTec. Combining Juno's world-leading chimeric antigen receptor (CAR-T) and T cell receptor (TCR)…

Latest round: IPO (2020)

Source: ChinaBulls — chinabulls.com

Last updated 2020-11-01